153 related articles for article (PubMed ID: 27014760)
1. Recovery from LCDD-associated Severe Liver Cholestasis: a Case Report and Literature Review.
Brilland B; Sayegh J; Croue A; Bridoux F; Subra JF; Augusto JF
J Gastrointestin Liver Dis; 2016 Mar; 25(1):99-103. PubMed ID: 27014760
[TBL] [Abstract][Full Text] [Related]
2. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
[TBL] [Abstract][Full Text] [Related]
3. Liver failure caused by light chain deposition disease associated with multiple myeloma.
Mena-Durán A; Muñoz Vicente E; Pareja Llorens G; Sanchis Cervera J
Intern Med; 2012; 51(7):773-6. PubMed ID: 22466837
[TBL] [Abstract][Full Text] [Related]
4. The rapid resolution of pseudohyperphosphatemia in an IGAκ multiple myeloma patient after therapy with a bortezomib-containing regimen: Report of the first case.
Maden M; Pamuk GE; Asoglu V; Pamuk ON
J Cancer Res Ther; 2015; 11(4):1043. PubMed ID: 26881672
[No Abstract] [Full Text] [Related]
5. Immunoglobulin A nephropathy in a patient with IgG kappa light-chain myeloma.
Chandra A; Kaul A; Aggarwal V
Saudi J Kidney Dis Transpl; 2017; 28(4):937-941. PubMed ID: 28748903
[TBL] [Abstract][Full Text] [Related]
6. Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome.
Michopoulos S; Petraki K; Petraki C; Dimopoulos MA
Dig Dis Sci; 2002 Apr; 47(4):730-4. PubMed ID: 11991600
[TBL] [Abstract][Full Text] [Related]
7. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
8. Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation.
Jimenez-Zepeda VH; Vajpeyi R; John R; Trudel S
Int J Hematol; 2012 Jul; 96(1):125-31. PubMed ID: 22573235
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell myeloma initially diagnosed as light-chain deposition disease on liver biopsy: A case report and literature review.
Jeong JY; Yang HT; Cho SH; Lee YR; Kim J; Kang MK; Hong J; Moon JH; Seo AN
Medicine (Baltimore); 2023 Mar; 102(13):e33406. PubMed ID: 37000077
[TBL] [Abstract][Full Text] [Related]
10. Crystalline cast nephropathy in a patient with IgD lambda myeloma.
Kumakura S; Nakaya I; Sakuma T; Sato H; Soma J
Clin Exp Nephrol; 2016 Jun; 20(3):491-2. PubMed ID: 26515717
[No Abstract] [Full Text] [Related]
11. [Jaundice secondary to intrahepatic deposit of light chains as a presenting form of multiple myeloma].
Macías Robles MD; Navia-Osorio García-Braga JM; Menéndez Caro JL; Velasco Alonso J; López Lagunas I
An Med Interna; 1994 Feb; 11(2):74-6. PubMed ID: 8193237
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Light Chain Deposition Disease Mimicking Immunoglobulin Light Chain Amyloidosis: Two Branches of the Same Tree.
Osanami A; Yano T; Takemura G; Ikeda H; Inyaku M; Toda Y; Kamiyama N; Sugawara H; Gocho Y; Fujito T; Nagano N; Takahashi S; Muranaka A; Tanaka M; Moniwa N; Murase K; Takada K; Kuroda H; Ogawa Y; Miura T
Circ Cardiovasc Imaging; 2020 Sep; 13(9):e010478. PubMed ID: 32873072
[No Abstract] [Full Text] [Related]
13. Light chain deposition disease involving kidney and liver in a patient with IgD myeloma.
Tsushima T; Suzuki T; Terao T; Miura D; Narita K; Takeuchi M; Shimuzu A; Matsue K
BMC Nephrol; 2021 Jan; 22(1):40. PubMed ID: 33485303
[TBL] [Abstract][Full Text] [Related]
14. Myeloma and severe cholestasis.
Licht A; Maurer R; Oelz O
Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of nephrotic syndrome induced by lambda light chain deposition disease using lenalidomide: A case report and review of the literature
.
Mima A; Nagahara D; Tansho K
Clin Nephrol; 2018 Jun; 89(6):461-468. PubMed ID: 29393843
[TBL] [Abstract][Full Text] [Related]
16. Kappa light chain myeloma with initial cutaneous involvement.
Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
[No Abstract] [Full Text] [Related]
17. Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure.
Gharwan H; Truica CI
Med Oncol; 2012 Jun; 29(2):1197-201. PubMed ID: 21479696
[TBL] [Abstract][Full Text] [Related]
18. [A rare case of cholestasis and macrohematuria in a 52-year-old patient].
Arkenau HT; Widjaja A
Med Klin (Munich); 2002 Aug; 97(8):480-3. PubMed ID: 12229247
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
Mohan M; Buros A; Mathur P; Gokden N; Singh M; Susanibar S; Jo Kamimoto J; Hoque S; Radhakrishnan M; Matin A; Davis C; Grazziutti M; Thanendrarajan S; van Rhee F; Zangari M; Davies F; Morgan G; Epstein J; Barlogie B; Schinke C
Am J Hematol; 2017 Aug; 92(8):739-745. PubMed ID: 28383130
[TBL] [Abstract][Full Text] [Related]
20. Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide.
Weisel KC; Böckeler M; Bianchi L; Terracciano LM; Mayer F; Kanz L
Int J Hematol; 2009 Jan; 89(1):91-94. PubMed ID: 19101782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
